283 related articles for article (PubMed ID: 19451656)
21. Transfusions increase with nationally driven reimbursement changes of erythropoiesis stimulating agents for chemotherapy-induced anemia.
Yu JM; Shord SS; Cuellar S
J Oncol Pharm Pract; 2011 Dec; 17(4):360-5. PubMed ID: 20826550
[TBL] [Abstract][Full Text] [Related]
22. Healthcare expenditure and resource utilization in patients with anaemia and chronic kidney disease: a retrospective claims database analysis.
Wish J; Schulman K; Law A; Nassar G
Kidney Blood Press Res; 2009; 32(2):110-8. PubMed ID: 19372704
[TBL] [Abstract][Full Text] [Related]
23. Trends in anemia management practices in patients receiving hemodialysis and peritoneal dialysis: a retrospective cohort analysis.
Wetmore JB; Peng Y; Monda KL; Kats AM; Kim DH; Bradbury BD; Collins AJ; Gilbertson DT
Am J Nephrol; 2015; 41(4-5):354-61. PubMed ID: 26107376
[TBL] [Abstract][Full Text] [Related]
24. Costs of managing anemia with erythropoiesis-stimulating agents during hemodialysis: a time and motion study.
Schiller B; Doss S; DE Cock E; Del Aguila MA; Nissenson AR
Hemodial Int; 2008 Oct; 12(4):441-9. PubMed ID: 19090867
[TBL] [Abstract][Full Text] [Related]
25. Trends in anemia care in non-dialysis-dependent chronic kidney disease (CKD) patients in the United States (2006-2015).
Park H; Liu X; Henry L; Harman J; Ross EA
BMC Nephrol; 2018 Nov; 19(1):318. PubMed ID: 30413150
[TBL] [Abstract][Full Text] [Related]
26. Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5.
Murtagh FE; Marsh JE; Donohoe P; Ekbal NJ; Sheerin NS; Harris FE
Nephrol Dial Transplant; 2007 Jul; 22(7):1955-62. PubMed ID: 17412702
[TBL] [Abstract][Full Text] [Related]
27. Hemoglobin level variability: anemia management among variability groups.
Gilbertson DT; Peng Y; Bradbury B; Ebben JP; Collins AJ
Am J Nephrol; 2009; 30(6):491-8. PubMed ID: 19786739
[TBL] [Abstract][Full Text] [Related]
28. Quality of life in CKD patients treated with erythropoiesis-stimulating agents.
Parfrey PS; Wish T
Am J Kidney Dis; 2010 Mar; 55(3):423-5. PubMed ID: 20189050
[No Abstract] [Full Text] [Related]
29. [Management of anemia in chronic kidney disease].
López Gómez JM
Nefrologia; 2008; 28 Suppl 3():63-6. PubMed ID: 19018741
[TBL] [Abstract][Full Text] [Related]
30. [Anemia: guidelines comparison].
Del Vecchio L
G Ital Nefrol; 2009; 26(6):686-94. PubMed ID: 19918751
[TBL] [Abstract][Full Text] [Related]
31. ORAMA: a study to investigate EBPG impact on renal anaemia - design and baseline data.
Locatelli F; Covic A; Macdougall IC; Wiecek A;
J Nephrol; 2008; 21(4):592-603. PubMed ID: 18651551
[TBL] [Abstract][Full Text] [Related]
32. [Erythropoesis-stimulating agents: past, present and future].
Kes P; Basić-Jukić N
Acta Med Croatica; 2009 Sep; 63 Suppl 1():3-6. PubMed ID: 20235351
[TBL] [Abstract][Full Text] [Related]
33. Arterial hypertension induced by erythropoietin and erythropoiesis-stimulating agents (ESA).
Krapf R; Hulter HN
Clin J Am Soc Nephrol; 2009 Feb; 4(2):470-80. PubMed ID: 19218474
[TBL] [Abstract][Full Text] [Related]
34. Changes in the use of erythropoiesis-stimulating agents (ESAs) and red blood cell transfusion in patients with cancer amidst regulatory and reimbursement changes.
Gawade PL; Berlin JA; Henry DH; Tomita D; Brooks BD; Franklin J; Bradbury BD; Critchlow CW
Pharmacoepidemiol Drug Saf; 2017 Nov; 26(11):1357-1366. PubMed ID: 28809079
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the Modification of Diet in Renal Disease and Cockcroft-Gault equations for dosing antimicrobials.
Hermsen ED; Maiefski M; Florescu MC; Qiu F; Rupp ME
Pharmacotherapy; 2009 Jun; 29(6):649-55. PubMed ID: 19476418
[TBL] [Abstract][Full Text] [Related]
36. Anemia management in chronic kidney disease.
Gillespie BS; Inrig JK; Szczech LA
Hemodial Int; 2007 Jan; 11(1):15-20. PubMed ID: 17257350
[TBL] [Abstract][Full Text] [Related]
37. Blood transfusion practices in dialysis patients in a dynamic regulatory environment.
Hirth RA; Turenne MN; Wilk AS; Wheeler JR; Sleeman KK; Zhang W; Paul MA; Nahra TA; Messana JM
Am J Kidney Dis; 2014 Oct; 64(4):616-21. PubMed ID: 24560166
[TBL] [Abstract][Full Text] [Related]
38. Anemia and cardiovascular risk in the patient with kidney disease.
Fishbane S
Heart Fail Clin; 2008 Oct; 4(4):401-10. PubMed ID: 18760752
[TBL] [Abstract][Full Text] [Related]
39. Erythropoiesis-stimulating Agents and Anemia in Patients with Non-dialytic Chronic Kidney Disease.
Kim SM; Kim KM; Kwon SK; Kim HY
J Korean Med Sci; 2016 Jan; 31(1):55-60. PubMed ID: 26770038
[TBL] [Abstract][Full Text] [Related]
40. Anemia management in oncology and hematology.
Spivak JL; Gascón P; Ludwig H
Oncologist; 2009; 14 Suppl 1():43-56. PubMed ID: 19762516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
